Proteolysis targeting chimera (PROTAC)-driven antibody internalization of oncogenic cell surface receptors
Ezequiel J. Tolosa(Mayo Clinic), Aaron S. Mansfield(Mayo Clinic), Mitesh J. Borad(Jacksonville College), Jennifer Ayers-Ringler(Mayo Clinic), Amarnath Natarajan(University of Nebraska Medical Center), Shinichiro Suzuki(Kindai University), Farhad Kosari(Mayo Clinic), Janet Schaefer-Klein(Mayo Clinic), Lin Yang(Mayo Clinic), Jayapal Reddy Mallareddy(University of Nebraska Medical Center)
Cited by 12
Related Papers
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.5k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k